Marengo to Share Updated Clinical Data of Invikafusp Monotherapy Activity in PD1 resistant tumors in a Clinical Plenary Oral Presentation at AACR 2025
Press Releases
Marengo Therapeutics  
March 25, 2025

Marengo to Share Updated Clinical Data of Invikafusp Monotherapy Activity in PD1 resistant tumors in a Clinical Plenary Oral Presentation at AACR 2025

Data to be presented from the STARt-001 trial demonstrating single agent anti-tumor activity

avatar profile Olean Times Herald

Olean Times Herald


Local & Social